- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 4 x F09: NONAN-1-OL(Non-covalent)
- 4 x DGA: DIACYL GLYCEROL(Non-covalent)
DGA.2: 11 residues within 4Å:- Chain C: V.84, T.85, L.86, R.89, L.90
- Chain H: E.53
- Chain I: L.41, Y.45, Y.62, P.63, C.70
7 PLIP interactions:4 interactions with chain C, 2 interactions with chain I, 1 interactions with chain H- Hydrophobic interactions: C:L.86, C:L.90, I:Y.45, I:Y.62
- Water bridges: C:R.89
- Salt bridges: C:R.89
- Hydrogen bonds: H:E.53
DGA.10: 11 residues within 4Å:- Chain F: V.84, T.85, L.86, R.89, L.90
- Chain K: E.53
- Chain L: L.41, Y.45, Y.62, P.63, C.70
7 PLIP interactions:4 interactions with chain F, 1 interactions with chain K, 2 interactions with chain L- Hydrophobic interactions: F:L.86, F:L.90, L:Y.45, L:Y.62
- Water bridges: F:R.89
- Salt bridges: F:R.89
- Hydrogen bonds: K:E.53
DGA.18: 11 residues within 4Å:- Chain E: E.53
- Chain F: L.41, Y.45, Y.62, P.63, C.70
- Chain I: V.84, T.85, L.86, R.89, L.90
7 PLIP interactions:1 interactions with chain E, 4 interactions with chain I, 2 interactions with chain F- Hydrogen bonds: E:E.53
- Hydrophobic interactions: I:L.86, I:L.90, F:Y.45, F:Y.62
- Water bridges: I:R.89
- Salt bridges: I:R.89
DGA.26: 11 residues within 4Å:- Chain B: E.53
- Chain C: L.41, Y.45, Y.62, P.63, C.70
- Chain L: V.84, T.85, L.86, R.89, L.90
7 PLIP interactions:4 interactions with chain L, 2 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: L:L.86, L:L.90, C:Y.45, C:Y.62
- Water bridges: L:R.89
- Salt bridges: L:R.89
- Hydrogen bonds: B:E.53
- 24 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
K.3: 15 residues within 4Å:- Chain C: X.77, Y.78
- Chain F: X.77, Y.78
- Chain I: X.77, Y.78
- Chain L: X.77, Y.78
- Ligands: K.4, K.11, K.12, K.19, K.20, K.27, K.28
Ligand excluded by PLIPK.4: 19 residues within 4Å:- Chain C: V.76, X.77
- Chain F: V.76, X.77
- Chain I: V.76, X.77
- Chain L: V.76, X.77
- Ligands: K.3, K.5, K.11, K.12, K.13, K.19, K.20, K.21, K.27, K.28, K.29
Ligand excluded by PLIPK.5: 19 residues within 4Å:- Chain C: T.75, V.76
- Chain F: T.75, V.76
- Chain I: T.75, V.76
- Chain L: T.75, V.76
- Ligands: K.4, K.6, K.12, K.13, K.14, K.20, K.21, K.22, K.28, K.29, K.30
Ligand excluded by PLIPK.6: 11 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.13, K.14, K.21, K.22, K.29, K.30
Ligand excluded by PLIPK.7: 3 residues within 4Å:- Ligands: K.15, K.23, K.31
Ligand excluded by PLIPK.8: 7 residues within 4Å:- Chain C: Y.78
- Chain F: Y.78
- Chain I: Y.78
- Chain L: Y.78
- Ligands: K.16, K.24, K.32
Ligand excluded by PLIPK.11: 15 residues within 4Å:- Chain C: X.77, Y.78
- Chain F: X.77, Y.78
- Chain I: X.77, Y.78
- Chain L: X.77, Y.78
- Ligands: K.3, K.4, K.12, K.19, K.20, K.27, K.28
Ligand excluded by PLIPK.12: 19 residues within 4Å:- Chain C: V.76, X.77
- Chain F: V.76, X.77
- Chain I: V.76, X.77
- Chain L: V.76, X.77
- Ligands: K.3, K.4, K.5, K.11, K.13, K.19, K.20, K.21, K.27, K.28, K.29
Ligand excluded by PLIPK.13: 19 residues within 4Å:- Chain C: T.75, V.76
- Chain F: T.75, V.76
- Chain I: T.75, V.76
- Chain L: T.75, V.76
- Ligands: K.4, K.5, K.6, K.12, K.14, K.20, K.21, K.22, K.28, K.29, K.30
Ligand excluded by PLIPK.14: 11 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.6, K.13, K.21, K.22, K.29, K.30
Ligand excluded by PLIPK.15: 3 residues within 4Å:- Ligands: K.7, K.23, K.31
Ligand excluded by PLIPK.16: 7 residues within 4Å:- Chain C: Y.78
- Chain F: Y.78
- Chain I: Y.78
- Chain L: Y.78
- Ligands: K.8, K.24, K.32
Ligand excluded by PLIPK.19: 15 residues within 4Å:- Chain C: X.77, Y.78
- Chain F: X.77, Y.78
- Chain I: X.77, Y.78
- Chain L: X.77, Y.78
- Ligands: K.3, K.4, K.11, K.12, K.20, K.27, K.28
Ligand excluded by PLIPK.20: 19 residues within 4Å:- Chain C: V.76, X.77
- Chain F: V.76, X.77
- Chain I: V.76, X.77
- Chain L: V.76, X.77
- Ligands: K.3, K.4, K.5, K.11, K.12, K.13, K.19, K.21, K.27, K.28, K.29
Ligand excluded by PLIPK.21: 19 residues within 4Å:- Chain C: T.75, V.76
- Chain F: T.75, V.76
- Chain I: T.75, V.76
- Chain L: T.75, V.76
- Ligands: K.4, K.5, K.6, K.12, K.13, K.14, K.20, K.22, K.28, K.29, K.30
Ligand excluded by PLIPK.22: 11 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.6, K.13, K.14, K.21, K.29, K.30
Ligand excluded by PLIPK.23: 3 residues within 4Å:- Ligands: K.7, K.15, K.31
Ligand excluded by PLIPK.24: 7 residues within 4Å:- Chain C: Y.78
- Chain F: Y.78
- Chain I: Y.78
- Chain L: Y.78
- Ligands: K.8, K.16, K.32
Ligand excluded by PLIPK.27: 15 residues within 4Å:- Chain C: X.77, Y.78
- Chain F: X.77, Y.78
- Chain I: X.77, Y.78
- Chain L: X.77, Y.78
- Ligands: K.3, K.4, K.11, K.12, K.19, K.20, K.28
Ligand excluded by PLIPK.28: 19 residues within 4Å:- Chain C: V.76, X.77
- Chain F: V.76, X.77
- Chain I: V.76, X.77
- Chain L: V.76, X.77
- Ligands: K.3, K.4, K.5, K.11, K.12, K.13, K.19, K.20, K.21, K.27, K.29
Ligand excluded by PLIPK.29: 19 residues within 4Å:- Chain C: T.75, V.76
- Chain F: T.75, V.76
- Chain I: T.75, V.76
- Chain L: T.75, V.76
- Ligands: K.4, K.5, K.6, K.12, K.13, K.14, K.20, K.21, K.22, K.28, K.30
Ligand excluded by PLIPK.30: 11 residues within 4Å:- Chain C: T.75
- Chain F: T.75
- Chain I: T.75
- Chain L: T.75
- Ligands: K.5, K.6, K.13, K.14, K.21, K.22, K.29
Ligand excluded by PLIPK.31: 3 residues within 4Å:- Ligands: K.7, K.15, K.23
Ligand excluded by PLIPK.32: 7 residues within 4Å:- Chain C: Y.78
- Chain F: Y.78
- Chain I: Y.78
- Chain L: Y.78
- Ligands: K.8, K.16, K.24
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Matulef, K. et al., Individual Ion Binding Sites in the K(+) Channel Play Distinct Roles in C-type Inactivation and in Recovery from Inactivation. Structure (2016)
- Release Date
- 2016-04-20
- Peptides
- Antibody Fab Fragment Light Chain: ADGJ
Antibody Fab Fragment Light Chain: BEHK
pH-gated potassium channel KcsA: CFIL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AG
AJ
AB
BE
BH
BK
BC
CF
CI
CL
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 4 x F09: NONAN-1-OL(Non-covalent)
- 4 x DGA: DIACYL GLYCEROL(Non-covalent)
- 24 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Matulef, K. et al., Individual Ion Binding Sites in the K(+) Channel Play Distinct Roles in C-type Inactivation and in Recovery from Inactivation. Structure (2016)
- Release Date
- 2016-04-20
- Peptides
- Antibody Fab Fragment Light Chain: ADGJ
Antibody Fab Fragment Light Chain: BEHK
pH-gated potassium channel KcsA: CFIL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
AG
AJ
AB
BE
BH
BK
BC
CF
CI
CL
C - Membrane
-
We predict this structure to be a membrane protein.